Background illustration for clinical trials search

Paid Clinical Trials Norman

Discover 566 paid clinical trials in Norman, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Oklahoma City OK, Prosper TX, Carrollton TX, Katy TX,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase 1, Phase 2, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: Oklahoma City OK, North Little Rock AR, Omaha NE,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase 3, Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

for
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Location: Edmond OK, Dallas TX, Arlington TX, Springdale AR,
Sponsor: Adverum Biotechnologies, Inc.

Sex: All

Age: 50+

Code: NCT07482176

Phase 3, Recruiting

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

for
Aortic Stenosis
Location: Oklahoma City OK, Wichita KS, Kansas City KS,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18 - 70+

Code: NCT06777368

Recruiting

HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs

for
Degenerative Disc Disease (DDD)
Location: Edmond OK, Tyler TX, Shreveport LA, Overland Park KS,
Sponsor: ReGelTec, Inc.

Sex: All

Age: 22 - 70+

Code: NCT06011551

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Chickasha OK, Allen TX, Carrollton TX, Dallas TX,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase 3, Recruiting